<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK169615" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK169615/" /><meta name="ncbi_pagename" content="Biotin-Thiamine-Responsive Basal Ganglia Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Biotin-Thiamine-Responsive Basal Ganglia Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Biotin-Thiamine-Responsive Basal Ganglia Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/11/21" /><meta name="citation_author" content="Brahim Tabarki" /><meta name="citation_author" content="Amal Al-Hashem" /><meta name="citation_author" content="Majid Alfadhel" /><meta name="citation_pmid" content="24260777" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK169615/" /><meta name="citation_keywords" content="Biotin-Responsive Basal Ganglia Disease" /><meta name="citation_keywords" content="BTBGD" /><meta name="citation_keywords" content="Thiamine Transporter-2 Deficiency" /><meta name="citation_keywords" content="Biotin-Responsive Basal Ganglia Disease" /><meta name="citation_keywords" content="BTBGD" /><meta name="citation_keywords" content="Thiamine Transporter-2 Deficiency" /><meta name="citation_keywords" content="Thiamine transporter 2" /><meta name="citation_keywords" content="SLC19A3" /><meta name="citation_keywords" content="Biotin-Thiamine-Responsive Basal Ganglia Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Biotin-Thiamine-Responsive Basal Ganglia Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Brahim Tabarki" /><meta name="DC.Contributor" content="Amal Al-Hashem" /><meta name="DC.Contributor" content="Majid Alfadhel" /><meta name="DC.Date" content="2013/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK169615/" /><meta name="description" content="Biotin-thiamine-responsive basal ganglia disease (BTBGD) is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or surgery. Less frequently, BTBGD presents as chronic or slowly progressive dystonia, seizures, and/or psychomotor delay. Although onset is usually in childhood (ages three to ten 10 years), it is extremely variable, ranging from the newborn period to adulthood. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days." /><meta name="og:title" content="Biotin-Thiamine-Responsive Basal Ganglia Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Biotin-thiamine-responsive basal ganglia disease (BTBGD) is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or surgery. Less frequently, BTBGD presents as chronic or slowly progressive dystonia, seizures, and/or psychomotor delay. Although onset is usually in childhood (ages three to ten 10 years), it is extremely variable, ranging from the newborn period to adulthood. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK169615/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bgd-biotin/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK169615/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CE928E04123910000000000680023.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK169615_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK169615_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bietti-cd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/biotin/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK169615_"><span class="title" itemprop="name">Biotin-Thiamine-Responsive Basal Ganglia Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Biotin-Responsive Basal Ganglia Disease, BTBGD, Thiamine Transporter-2 Deficiency</div><p class="contrib-group"><span itemprop="author">Brahim Tabarki</span>, MD, <span itemprop="author">Amal Al-Hashem</span>, MD, and <span itemprop="author">Majid Alfadhel</span>, MD, MHSc, FCCMG.</p><a data-jig="ncbitoggler" href="#__NBK169615_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK169615_ai__"><div class="contrib half_rhythm"><span itemprop="author">Brahim Tabarki</span>, MD<div class="affiliation small">Prince Sultan Military and Medical City<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@ikrabatb" class="oemail">moc.liamtoh@ikrabatb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Amal Al-Hashem</span>, MD<div class="affiliation small">Prince Sultan Military and Medical City<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.dem.cmmsp@mehsahlaa" class="oemail">as.dem.cmmsp@mehsahlaa</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Majid Alfadhel</span>, MD, MHSc, FCCMG<div class="affiliation small">King Abdulaziz Medical City<br />King Saud Bin Abdulaziz University for Health Sciences<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@lehdaflard" class="oemail">moc.oohay@lehdaflard</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 21, 2013</span>.</p><p><em>Estimated reading time: 11 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bgd-biotin.Summary" itemprop="description"><h2 id="_bgd-biotin_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Biotin-thiamine-responsive basal ganglia disease (BTBGD) is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or surgery. Less frequently, BTBGD presents as chronic or slowly progressive dystonia, seizures, and/or psychomotor delay. Although onset is usually in childhood (ages three to ten 10 years), it is extremely variable, ranging from the newborn period to adulthood. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Brain MRI shows symmetric and bilateral increased T<sub>2</sub> signal intensity in the central part of caudate head and part or all of the putamen, as well as involvement of the globi pallidi, thalami, infra-and supratentorial brain cortex, brain stem, and cerebellum. During acute crises, severe vasogenic edema can be observed; chronic changes include atrophy, necrosis, and gliosis in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> regions. The diagnosis of BTBGD is confirmed by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC19A3</i> pathogenic variants.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Biotin (5-10 mg/kg/day) and thiamine (in doses ranging from 300 to 900 mg) are given orally as early in the disease course as possible and are continued lifelong. Symptoms typically resolve within days. Acute encephalopathic episodes may require care in an ICU to manage seizures and increased intracranial pressure; during acute decompensations thiamine may be increased to double the regular dose and be given intravenously. Treatment of dystonia is symptomatic and includes administration of L-dopa. Rehabilitation, physiotherapy, occupational therapy, and speech therapy as needed. Adaptation of educational programs to meet individual needs.</p><p><i>Prevention of primary manifestations:</i> Prompt administration of biotin and thiamine early in the disease course.</p><p><i>Surveillance:</i> Evaluation every six months by the treating subspecialists.</p><p><i>Agents/circumstances to avoid:</i> Stress, trauma.</p><p><i>Evaluation of relatives at risk:</i> If the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> on at-risk relatives (e.g., sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>) in order to begin thiamine and biotin therapy as soon as possible in all individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC19A3</i> pathogenic variants, even those who are asymptomatic.</p><p><i>Pregnancy management:</i> Affected women should continue thiamine and biotin during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>BTBGD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="bgd-biotin.Diagnosis"><h2 id="_bgd-biotin_Diagnosis_">Diagnosis</h2><p><b>Biotin-thiamine-responsive basal ganglia disease (BTBGD) is suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Acute/subacute encephalopathy with seizures, extra pyramidal manifestations (dystonia, cogwheel rigidity, dysarthria, dysphagia), and pyramidal tract signs (quadriparesis, hyperreflexia) typically in a child age 3-10 years and usually preceded by febrile illness or some other stress. Cerebellar signs, supranuclear facial nerve palsy, external ophthalmoplegia, and ataxia are variably present.</div></li><li class="half_rhythm"><div class="half_rhythm">Brain MRI showing the following:</div><ul><li class="half_rhythm"><div>Bilateral and symmetric increased T<sub>2</sub> signal intensity in the caudate nucleus, putamen, thalamus, infra-and supratentorial brain cortex, and brain stem [<a class="bk_pop" href="#bgd-biotin.REF.ozand.1998.1267">Ozand et al 1998</a>]</div></li><li class="half_rhythm"><div>Vasogenic edema during acute crises as demonstrated by diffusion-weighted imaging (DWI)/apparent diffusion coefficient (ADC) MRI</div></li><li class="half_rhythm"><div>Chronic changes including diffuse cerebral cortical and (to a lesser extent) cerebellar atrophy, and gliosis in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> regions [<a class="bk_pop" href="#bgd-biotin.REF.yamada.2010.171">Yamada et al 2010</a>]</div></li><li class="half_rhythm"><div>Spinal cord involvement (seen in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual) [<a class="bk_pop" href="#bgd-biotin.REF.alfadhel.2013.83">Alfadhel et al 2013</a>]</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Normal laboratory investigations, including tandem mass spectrometry of blood; urine gas chromatography-mass spectrometry (GC-MS); serum concentrations of lactic acid*, ammonia, biotin, and thiamine; serum biotinidase enzyme activity; urine amino acids; plasma amino acids; liver enzymes; coagulation profile; lipid profile; and cerebrospinal fluid (CSF) cell count, protein, glucose, and cultures</div><div class="half_rhythm">* Serum concentration of lactic acid may be high in the acute stage.</div></li><li class="half_rhythm"><div class="half_rhythm">Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance. Note: (1) Presumably <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (but undiagnosed) sibs may have had unexplained coma or encephalopathy. (2) To date, <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> has been reported in a large portion of families [<a class="bk_pop" href="#bgd-biotin.REF.alfadhel.2013.83">Alfadhel et al 2013</a>, <a class="bk_pop" href="#bgd-biotin.REF.tabarki.2013.261">Tabarki et al 2013</a>].</div></li></ul><p><b>Biotin-thiamine-responsive basal ganglia disease (BTBGD) is confirmed</b> in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC19A3</i> pathogenic variants (see <a class="figpopup" href="/books/NBK169615/table/bgd-biotin.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figbgdbiotinTmoleculargenetictestingu" rid-ob="figobbgdbiotinTmoleculargenetictestingu">Table 1</a>).</p><p>Sequencing of <i>SLC19A3</i> is likely to identify pathogenic variants on both alleles and therefore provide molecular confirmation of BTBGD in most individuals with typical clinical and radiologic findings. Although large <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions have not been reported, apparent heterozygosity for a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC19A3</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> in a typically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may indicate compound heterozygosity for a second unidentified pathogenic variant and warrants <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis.</p><div id="bgd-biotin.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Biotin-Thiamine-Responsive Basal Ganglia Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169615/table/bgd-biotin.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bgd-biotin.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC19A3</i></td><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">42/46&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications</td><td headers="hd_h_bgd-biotin.T.molecular_genetic_testing_u_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bgd-biotin.TF.1.1"><p class="no_margin">See <a href="/books/NBK169615/#bgd-biotin.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="bgd-biotin.TF.1.2"><p class="no_margin">See <a href="#bgd-biotin.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="bgd-biotin.TF.1.3"><p class="no_margin">The ability of the test method used to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="bgd-biotin.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="bgd-biotin.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#bgd-biotin.REF.zeng.2005.16">Zeng et al [2005]</a>, <a class="bk_pop" href="#bgd-biotin.REF.debs.2010.126">Debs et al [2010]</a>, <a class="bk_pop" href="#bgd-biotin.REF.tabarki.2013.261">Tabarki et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="bgd-biotin.TF.1.6"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="bgd-biotin.TF.1.7"><p class="no_margin">No deletions or duplications involving <i>SLC19A3</i> have been reported to cause BTBGD.</p></div></dd></dl></div></div></div></div><div id="bgd-biotin.Clinical_Characteristics"><h2 id="_bgd-biotin_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bgd-biotin.Clinical_Description"><h3>Clinical Description</h3><p>Biotin-thiamine-responsive basal ganglia disease (BTBGD) usually presents in children of preschool age or early school age (i.e., ages 3-10 years). In one report onset was at age one month [<a class="bk_pop" href="#bgd-biotin.REF.p_rezdue_as.2013.e1670">P&#x000e9;rez-Due&#x000f1;as et al 2013</a>] and in another at age 20 years [<a class="bk_pop" href="#bgd-biotin.REF.debs.2010.126">Debs et al 2010</a>].</p><p>Most commonly BTBGD is characterized by recurrent subacute onset of encephalopathy manifest as confusion, generalized seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and dysphagia, eventually leading to coma and even death. This encephalopathy may be associated with variable degree of raised intracranial pressure. Dystonia and cogwheel rigidity are nearly always present. Hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness, mild trauma, or stress.</p><p>Less frequently, BTBGD presents as a chronic or slowly progressive condition characterized by dystonia, seizures, and psychomotor delay.</p><p>Seizures are mainly simple partial or generalized seizures and are easily controlled with antiepileptic drugs. Infantile spasms also occur [<a class="bk_pop" href="#bgd-biotin.REF.yamada.2010.171">Yamada et al 2010</a>].</p><p>Administration of biotin and thiamine early in the disease course results in partial or complete clinical improvement within days (see <a href="#bgd-biotin.Management">Management</a>). Lifelong treatment is required. Treatment initiated later in the disease course or lack of treatment may result in death or chronic neurologic sequelae including dystonia, quadriparesis, epilepsy, or mild intellectual disability may ensue.</p></div><div id="bgd-biotin.Prevalence"><h3>Prevalence</h3><p>Prevalence is unknown.</p><p>The disease is pan ethnic; however, it is most prevalent in Saudi Arabia.</p></div><div id="bgd-biotin.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations are poor. Despite having the same pathogenic variants, children from the same family have extremely variable outcomes, ranging from normal to severely handicapped [<a class="bk_pop" href="#bgd-biotin.REF.alfadhel.2013.83">Alfadhel et al 2013</a>].</p></div></div><div id="bgd-biotin.Genetically_Related_Allelic_D"><h2 id="_bgd-biotin_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SLC19A3</i> pathogenic variants (<a class="figpopup" href="/books/NBK169615/table/bgd-biotin.T.slc19a3_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figbgdbiotinTslc19a3pathogenicvariants" rid-ob="figobbgdbiotinTslc19a3pathogenicvariants">p.Lys44Glu</a>, <a class="figpopup" href="/books/NBK169615/table/bgd-biotin.T.slc19a3_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figbgdbiotinTslc19a3pathogenicvariants" rid-ob="figobbgdbiotinTslc19a3pathogenicvariants">p.Glu320Gln</a>) have been associated with Wernicke-like encephalopathy, characterized by acute onset of epilepsy, ataxia, nystagmus, and ophthalmoplegia in the second decade of life [<a class="bk_pop" href="#bgd-biotin.REF.kono.2009.1792">Kono et al 2009</a>].</p><p>Homozygosity for the <i>SLC19A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.958 G&#x0003e;C (p.Glu320Gln) causes epileptic seizures in early infancy, severe psychomotor retardation, and characteristic findings on brain MRI of progressive brain atrophy and bilateral thalamic and basal ganglia alterations in signal intensity.</p><p>Early-infantile, lethal encephalopathy caused by pathogenic variants in <i>SLC19A3</i> has been reported [<a class="bk_pop" href="#bgd-biotin.REF.kevelam.2013.1534">Kevelam et al 2013</a>]<i>.</i></p><p>Early-childhood fatal Leigh syndrome caused by novel <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC19A3</i> has been reported [<a class="bk_pop" href="#bgd-biotin.REF.gerards.2013.882">Gerards et al 2013</a>]<i>.</i></p></div><div id="bgd-biotin.Differential_Diagnosis"><h2 id="_bgd-biotin_Differential_Diagnosis_">Differential Diagnosis</h2><p>Additional disorders in the differential diagnosis:</p><ul><li class="half_rhythm"><div>Wernicke encephalopathy</div></li><li class="half_rhythm"><div>Organic acid disorders</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a> (including Leigh syndrome)</div></li><li class="half_rhythm"><div>Toxic encephalopathy</div></li><li class="half_rhythm"><div>Infectious encephalopathy</div></li><li class="half_rhythm"><div>Inflammatory disease (including CNS vasculitis)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/wilson/">Wilson disease</a>&#x000a0;*</div></li><li class="half_rhythm"><div><a href="/books/n/gene/huntington/">Juvenile Huntington disease</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/xdp/">Torsion dystonia</a> (DYT1)</div></li><li class="half_rhythm"><div>Dopa-responsive dystonia (see <a href="/books/n/gene/thdrd/">Tyrosine Hydroxylase Deficiency</a>, <a href="/books/n/gene/drd/">GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</a>, and <a href="/books/n/gene/spr-def/">Sepiapterin Reductase Deficiency</a>)&#x000a0;*</div></li><li class="half_rhythm"><div>Acute disseminated encephalomyelitis (ADEM)</div></li></ul><p>* Dopa-responsive dystonia and Wilson disease are important to consider because they are treatable.</p><p>In its chronic stage BTBGD shares clinical features with several conditions including <a href="/books/n/gene/wilson/">Wilson disease</a>, <a href="/books/n/gene/huntington/">juvenile Huntington disease</a>, and <a href="/books/n/gene/xdp/">torsion dystonia</a> (DYT1); however, BTBGD can be differentiated by its acute to subacute presentation.</p><p>See <a href="http://www.omim.org/phenotypicSeries/PS249270" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Thiamine-responsive dysfunction syndrome: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="bgd-biotin.Management"><h2 id="_bgd-biotin_Management_">Management</h2><div id="bgd-biotin.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with biotin-thiamine responsive basal ganglia disease (BTBGD), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic evaluation by a pediatric neurologist</div></li><li class="half_rhythm"><div>Assessments by specialists in rehabilitation medicine, physiotherapy, occupational therapy, and speech therapy</div></li><li class="half_rhythm"><div>Psychology evaluation for assessment of IQ</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="bgd-biotin.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Appropriate treatment includes the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">ICU care during acute encephalopathic episode, including treatment of seizures and increased intracranial pressure</div></li><li class="half_rhythm"><div class="half_rhythm">Biotin and thiamine therapy. Biotin is given as 5-10 mg/kg and thiamine as 300-900 mg orally. (Note: In one report 20 mg/kg/day in a neonate was used.)</div><div class="half_rhythm">Symptoms typically resolve within days. (Note: <i>SLC19A3</i> encodes a second thiamine transport and some patients respond only to thiamine.)</div><ul><li class="half_rhythm"><div>Biotin and thiamine need to be given lifelong.</div></li><li class="half_rhythm"><div>During acute decompensation thiamine may be increased to double the regular dose and given intravenously.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">In the acute stage empiric treatment with antimicrobial/antiviral agents. Recommended until infectious causes of the acute/subacute encephalopathy are ruled out.</div></li><li class="half_rhythm"><div class="half_rhythm">Fever control. Paramount as fever downregulates <i>SLC19A3</i> and may exacerbate the disease.</div></li><li class="half_rhythm"><div class="half_rhythm">Antiepileptic drugs for effective control of seizures</div></li><li class="half_rhythm"><div class="half_rhythm">Symptomatic treatment of dystonia, including administration of L-dopa</div></li><li class="half_rhythm"><div class="half_rhythm">Rehabilitation, physiotherapy, occupational therapy, and speech therapy</div></li><li class="half_rhythm"><div class="half_rhythm">Educational programs adapted to individual needs</div></li><li class="half_rhythm"><div class="half_rhythm">Education of the family regarding the importance of lifelong compliance with medical therapy</div></li></ul></div><div id="bgd-biotin.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>Appropriate measures include the following:</p><ul><li class="half_rhythm"><div>Prompt administration of biotin and thiamine early in the disease course (see <a href="#bgd-biotin.Treatment_of_Manifestations">Treatment of Manifestations</a>)</div></li><li class="half_rhythm"><div>Avoidance of triggers/stressors including trauma and surgery</div></li></ul></div><div id="bgd-biotin.Surveillance"><h3>Surveillance</h3><p>Evaluation every six months by the treating subspecialists (pediatric neurologist, metabolic genetic specialist, physiotherapist, and psychologists) is appropriate.</p></div><div id="bgd-biotin.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Stress and trauma should be avoided as they can precipitate acute attacks.</p></div><div id="bgd-biotin.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>If the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> on at-risk relatives (e.g., sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>) in order to begin biotin and thiamine therapy as soon as possible in all individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC19A3</i> pathogenic variants, even those who are asymptomatic.</p><p>See <a href="#bgd-biotin.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bgd-biotin.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Affected women should continue biotin and thiamine therapy during pregnancy. No information regarding risk to the fetus of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother is available.</p></div><div id="bgd-biotin.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="bgd-biotin.Other"><h3>Other</h3><p>Routine administration of immunizations is recommended (without any specific precautions).</p></div></div><div id="bgd-biotin.Genetic_Counseling"><h2 id="_bgd-biotin_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bgd-biotin.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Biotin-thiamine-responsive basal ganglia disease (BTBGD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="bgd-biotin.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with BTBGD has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC19A</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="bgd-biotin.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p></div><div id="bgd-biotin.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#bgd-biotin.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bgd-biotin.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC19A3</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for BTBGD are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While decisions regarding prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="bgd-biotin.Resources"><h2 id="_bgd-biotin_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/biotin-thiamine-responsive-basal-ganglia-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Biotin-thiamine-responsive basal ganglia disease</a></div></li></ul></div><div id="bgd-biotin.Molecular_Genetics"><h2 id="_bgd-biotin_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bgd-biotin.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Biotin-Thiamine-Responsive Basal Ganglia Disease : Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169615/table/bgd-biotin.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bgd-biotin.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bgd-biotin.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/80704" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC19A3</i></a></td><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=80704" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q36<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BZV2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Thiamine transporter 2</a></td><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SLC19A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A3 database</a></td><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC19A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A3</a></td><td headers="hd_b_bgd-biotin.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC19A3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bgd-biotin.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bgd-biotin.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Biotin-Thiamine-Responsive Basal Ganglia Disease (<a href="/omim/606152,607483" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169615/table/bgd-biotin.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bgd-biotin.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606152" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606152</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3; SLC19A3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607483" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607483</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>SLC19A3</i> spans 32.91 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA, and consists of six exons with a start codon in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 and a TAA stop codon in exon 6. <i>SLC19A3</i> is a member of the SLC19 (solute carrier family 19) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> family (comprising <i>SLC19A1</i>, <i>SLC19A2</i>, and <i>SLC19A3</i>) that is responsible for the uptake of water-soluble vitamins into cells. For a detailed summary of gene and protein information, see <a href="/books/NBK169615/#bgd-biotin.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>SLC19A3</i> pathogenic variants described in persons with BTBGD include the following (in decreasing order of frequency): c.1264A&#x0003e;G, c.68G&#x0003e;T, c.74dupT, c.980-38dupA, and c.980-14A&#x0003e;G [<a class="bk_pop" href="#bgd-biotin.REF.zeng.2005.16">Zeng et al 2005</a>, <a class="bk_pop" href="#bgd-biotin.REF.debs.2010.126">Debs et al 2010</a>, <a class="bk_pop" href="#bgd-biotin.REF.alfadhel.2013.83">Alfadhel et al 2013</a>, <a class="bk_pop" href="#bgd-biotin.REF.tabarki.2013.261">Tabarki et al 2013</a>].</p><div id="bgd-biotin.T.slc19a3_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SLC19A3</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169615/table/bgd-biotin.T.slc19a3_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bgd-biotin.T.slc19a3_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.68G&#x0003e;T</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly23Val</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_025243.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_025243<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_079519.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_079519<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.74dupT</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser26LeufsTer19</td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.130A&#x0003e;G<br />(218A&#x0003e;G)</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys44Glu</td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.958G&#x0003e;C<br />(1047G&#x0003e;C)</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu320Gln</td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.980-38dupA</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.980-14A&#x0003e;G</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1264A&#x0003e;G</td><td headers="hd_h_bgd-biotin.T.slc19a3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr422Ala</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bgd-biotin.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><div id="bgd-biotin.T.summary_of_pathogenic_genot" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Summary of Pathogenic Genotypes Reported in BTBGD</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK169615/table/bgd-biotin.T.summary_of_pathogenic_genot/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bgd-biotin.T.summary_of_pathogenic_genot_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Location</th><th id="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC19A3</i> Genotypes</th><th id="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Individuals</th><th id="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Population</th></tr></thead><tbody><tr><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 5</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[1264A&#x0003e;G];[1264A&#x0003e;G]&#x000a0;<sup>1</sup></td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Saudi</td></tr><tr><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 3</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[958G&#x0003e;C ];[958G&#x0003e;C]&#x000a0;<sup>1</sup></td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Japanese</td></tr><tr><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 2</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[68G&#x0003e;T];[68G&#x0003e;T]&#x000a0;<sup>1</sup></td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yemeni, Moroccan</td></tr><tr><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 2 and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 3</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.[74dupT];[980-14A&#x0003e;G]&#x000a0;<sup>2</sup></td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_bgd-biotin.T.summary_of_pathogenic_genot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Portuguese</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bgd-biotin.TF.3.1"><p class="no_margin">Homozygous</p></div></dd><dt>2. </dt><dd><div id="bgd-biotin.TF.3.2"><p class="no_margin">Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC19A3</i> encodes thiamine transporter 2 (hTHTR2).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism of action of biotin remains unclear. The absence of deficient serum concentrations of biotin and thiamine and the efficacy of high doses of biotin in the treatment of biotin-thiamine-responsive basal ganglia disease (BTBGD) [<a class="bk_pop" href="#bgd-biotin.REF.ozand.1998.1267">Ozand et al 1998</a>, <a class="bk_pop" href="#bgd-biotin.REF.subramanian.2006.c851">Subramanian et al 2006</a>] suggest that high doses of biotin increase expression of hTHTR2, thus restoring some function of the mutated receptor. On the other hand, the new understanding of the function of <i>SCL19A3</i> highlights the major role of thiamine in the treatment of BTBGD.</p></div><div id="bgd-biotin.References"><h2 id="_bgd-biotin_References_">References</h2><div id="bgd-biotin.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.alfadhel.2013.83">Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, Al Balwi M, Al Rumayan A, Eyaid W, Al-Twaijri W. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:83.</span> [<a href="/pmc/articles/PMC3691666/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3691666</span></a>] [<a href="/pubmed/23742248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23742248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.debs.2010.126">Debs R, Depienne C, Rastetter A, Bellanger A, Degos B, Galanaud D, Keren B, Lyon-Caen O, Brice A, Sedel F. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. <span><span class="ref-journal">Arch Neurol. </span>2010;<span class="ref-vol">67</span>:126–30.</span> [<a href="/pubmed/20065143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20065143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.gerards.2013.882">Gerards M, Kamps R, van Oevelen J, Boesten I, Jongen E, de Koning B, Scholte HR, de Angst I, Schoonderwoerd K, Sefiani A, Ratbi I, Coppieters W, Karim L, de Coo R, van den Bosch B, Smeets H. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:882–90.</span> [<a href="/pubmed/23423671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23423671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.kevelam.2013.1534">Kevelam SH, Bugiani M, Salomons GS, Feigenbaum A, Blaser S, Prasad C, H&#x000e4;berle J, Baric I, Bakker IM, Postma NL, Kanhai WA, Wolf NI, Abbink TE, Waisfisz Q, Heutink P, van der Knaap MS. Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:1534–43.</span> [<a href="/pubmed/23482991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23482991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.kono.2009.1792">Kono S, Miyajima H, Yoshida K, Togawa A, Shirakawa K, Suzuki H. Mutations in a thiamine-transporter gene and Wernicke&#x02019;s-like encephalopathy. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:1792–4.</span> [<a href="/pubmed/19387023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19387023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.ozand.1998.1267">Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, Al Watban J, Al-Kawi MZ, Dabbagh O. Biotin-responsive basal ganglia disease: a novel entity. <span><span class="ref-journal">Brain. </span>1998;<span class="ref-vol">121</span>:1267–79.</span> [<a href="/pubmed/9679779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9679779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.p_rezdue_as.2013.e1670">P&#x000e9;rez-Due&#x000f1;as B, Serrano M, Rebollo M, Muchart J, Gargallo E, Dupuits C, Artuch R. Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency. <span><span class="ref-journal">Pediatrics. </span>2013;<span class="ref-vol">131</span>:e1670–5.</span> [<a href="/pubmed/23589815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23589815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.subramanian.2006.c851">Subramanian VS, Marchant JS, Said HM. Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2. <span><span class="ref-journal">Am J Physiol Cell Physiol. </span>2006;<span class="ref-vol">291</span>:C851–9.</span> [<a href="/pubmed/16790503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16790503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.tabarki.2013.261">Tabarki B, Al-Shafi S, Al-Shahwan S, Azmat S, Al-Hashem A. Al-Adwani, Biary N, Al-Zawahmah M, Khan S, Zuccoli G. Biotin-responsive basal ganglia disease revisited: clinical, neuroradiological, and genetic findings. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:261–7.</span> [<a href="/pubmed/23269594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23269594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.yamada.2010.171">Yamada K, Miura K, Hara K, Suzuki M, Nakanishi K, Kumagai T, Ishihara N, Yamada Y, Kuwano R, Tsuji S, Wakamatsu N. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. <span><span class="ref-journal">BMC Med Genet. </span>2010;<span class="ref-vol">11</span>:171.</span> [<a href="/pmc/articles/PMC3022826/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3022826</span></a>] [<a href="/pubmed/21176162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21176162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bgd-biotin.REF.zeng.2005.16">Zeng WQ, Al-Yamani E, Acierno JS Jr, Slaugenhaupt S, Gillis T, MacDonald ME, Ozand PT, Gusella JF. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:16–26.</span> [<a href="/pmc/articles/PMC1226189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226189</span></a>] [<a href="/pubmed/15871139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15871139</span></a>]</div></li></ul></div></div><div id="bgd-biotin.Chapter_Notes"><h2 id="_bgd-biotin_Chapter_Notes_">Chapter Notes</h2><div id="bgd-biotin.Acknowledgments"><h3>Acknowledgments</h3><p>We would like to thank Dr S Al Shafi Shatha and Dr Saad Al Shahwan, Division of Pediatric Neurology, PSMMC.</p></div><div id="bgd-biotin.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>28 May 2013 (aah) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK169615</span><span class="label">PMID: <a href="/pubmed/24260777" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24260777</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bietti-cd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/biotin/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK169615&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK169615/?report=reader">PubReader</a></li><li><a href="/books/NBK169615/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK169615" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK169615" style="display:none" title="Cite this Page"><div class="bk_tt">Tabarki B, Al-Hashem A, Alfadhel M. Biotin-Thiamine-Responsive Basal Ganglia Disease. 2013 Nov 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK169615/pdf/Bookshelf_NBK169615.pdf">PDF version of this page</a> (409K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bgd-biotin.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bgd-biotin.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bgd-biotin.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bgd-biotin.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bgd-biotin.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bgd-biotin.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bgd-biotin.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bgd-biotin.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bgd-biotin.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bgd-biotin.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bgd-biotin.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=80704[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC19A3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3061842" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3061842" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3061842" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3061842" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23742248" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.</a><span class="source">[Orphanet J Rare Dis. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, Al Balwi M, Al Rumayan A, Eyaid W, Al-Twaijri W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2013 Jun 6; 8:83. Epub 2013 Jun 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27905264" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.</a><span class="source">[Neurol Res. 2017]</span><div class="brieflinkpop offscreen_noflow">Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Algahtani H, Ghamdi S, Shirah B, Alharbi B, Algahtani R, Bazaid A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Res. 2017 Feb; 39(2):117-125. Epub 2016 Dec 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30054086" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?</a><span class="source">[Eur J Paediatr Neurol. 2018]</span><div class="brieflinkpop offscreen_noflow">Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kamaşak T, Havalı C, İnce H, Eyüboğlu İ, Çebi AH, Sahin S, Cansu A, Aydin K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Paediatr Neurol. 2018 Nov; 22(6):1139-1149. Epub 2018 Jul 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301610" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y, Kish S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24260777" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24260777" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04133d75f66d18aa034725">Biotin-Thiamine-Responsive Basal Ganglia Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Biotin-Thiamine-Responsive Basal Ganglia Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:56:13-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CE928E04123910000000000680023&amp;ncbi_session=CE8CE928E04133D1_0104SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK169615%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK169615&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK169615/&amp;ncbi_pagename=Biotin-Thiamine-Responsive Basal Ganglia Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CE928E04133D1_0104SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>